Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study

Comert G. K., Turkmen O., Boyraz G., Yalcin I., Altin D., Karalok A., ...More

BALKAN MEDICAL JOURNAL, vol.36, no.4, pp.229-234, 2019 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 4
  • Publication Date: 2019
  • Doi Number: 10.4274/balkanmedj.galenos.2019.2018.12.75
  • Journal Name: BALKAN MEDICAL JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.229-234
  • Keywords: Adjuvant, carcinosarcoma, chemotherapy, radiotherapy, uterine neoplasms, MIXED MULLERIAN TUMORS, PHASE-III TRIAL, RECURRENCE PATTERNS, UTERUS, IFOSFAMIDE, CISPLATIN, CHEMOTHERAPY, PACLITAXEL, LYMPHADENECTOMY, CARBOPLATIN
  • Ankara University Affiliated: Yes

Abstract

Background: Uterine carcinosarcoma is rare neoplasm that mostly presents as metastatic disease. Stage is one of the most important prognostic factor, however, the management of the early stage uterine carcinosarcoma is still controversial.